Mounjarixyl
Kalpa Pharmaceuticals

Mounjarixyl

63.00 USD 84.00 USD

MADE BY: Kalpa Pharmaceuticals
AMOUNT: 2ml vial 5mg/ml
DRUG CLASS: Peptides
ACTIVE LIFE:
AVERAGE DOSE:
LIVER TOXICITY:
AROMATIZATION RATE:
DHT CONVERSION:
DECREASE HPTA FUNCTION:
ANABOLIC/ ANDROGENIC RATE:
ACTIVE SUBSTANCE: Tirzepatide

Shipping From:
International
You will save 21.00 USD

Mounjarixyl Detailed

Kalpa Pharmaceuticals Tirzepatide 5mg vial

Kalpa Pharmaceuticals Tirzepatide 5mg is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, which is FDA-approved for treating type 2 diabetes mellitus.

It is important to note that tirzepatide is not approved for treating type-1 diabetes mellitus and has not been studied in patients with pancreatitis. Kalpa Tirzepatide is a GIP receptor and GLP-1 receptor agonist, leading to significantly improved glycemic control in type 2 diabetics and significant weight reduction.

Tirzepatide can also be used off-label for treating obesity. It is currently implemented as a second-line diabetes medication, similar to GLP-1 medications like semaglutide. It is a once-a-week subcutaneous injectable medication with incremental dose increases. Tirzepatide is a synthetic peptide; and a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist.

It is composed of 39 amino acids and is an analog of the gastric inhibitory polypeptide. Functionally, it stimulates insulin release from the pancreas and leads to a reduction of hyperglycemia. In addition, Tirzepatide also increases the levels of adiponectin. Its dual agonism ability leads to a more significant reduction of hyperglycemia than GLP-1 agonist agents alone and lowers the user's appetite.

Absorption: Tirzepatide has a bioavailability of approximately 80%. The time it takes to reach peak serum levels can range from 8 to 72 hours.
Distribution: The mean apparent steady-state volume of distribution(Vd) of tirzepatide is approximately 10.3 L. Tirzepatide is highly bound to plasma albumin (99%).
Metabolism: Once injected, the peptide structure undergoes proteolytic cleavage. In addition, the C20 fatty diacid composition undergoes beta-oxidation and amide hydrolysis.
Excretion: Tirzepatide has a half-life of 5 days, allowing once-weekly dosing, and is cleared in urine and feces in the form of metabolites.

No reviews found

Please log in to write Mounjarixyl review.

Related Offers
Tirzepatide 5 mg
Generic Peptides

MADE BY: Generic Peptide
AMOUNT: 2ml vial 5mg/ml
DRUG CLASS: Peptides
ACTIVE LIFE:
AVERAGE DOSE:
LIVER TOXICITY:
AROMATIZATION RATE:
DHT CONVERSION:
DECREASE HPTA FUNCTION:
ANABOLIC/ ANDROGENIC RATE:
ACTIVE SUBSTANCE: Tirzepatide

Products are shipping without brand label for security reasons.

95.00 USD  
Shipped USA Domestic
Tirzepatide 20 mg
Ordinary Steroids USA

MADE BY: Ordinary Steroids
AMOUNT: 2ml vial 5mg/ml
DRUG CLASS: Peptides
ACTIVE LIFE:
AVERAGE DOSE:
LIVER TOXICITY:
AROMATIZATION RATE:
DHT CONVERSION:
DECREASE HPTA FUNCTION:
ANABOLIC/ ANDROGENIC RATE:
ACTIVE SUBSTANCE: Tirzepatide

Products are shipping without brand label for security reasons.

210.00 USD  
Only 1 week left with this price
Tirzepatide 5mg
Dragon Pharma, Europe

MADE BY: Dragon Pharma
AMOUNT: 2 ml vials/5mg
DRUG CLASS:
ACTIVE LIFE:
AVERAGE DOSE:
ACTIVE SUBSTANCE: Tirzepatide

61.75 USD 95.00 USD
You will save 33.25 USD
Tirzepatide 10 mg
Generic Peptides

MADE BY: Generic Peptide
AMOUNT: 2ml vial 10mg/ml
DRUG CLASS: Peptides
ACTIVE LIFE:
AVERAGE DOSE:
LIVER TOXICITY:
AROMATIZATION RATE:
DHT CONVERSION:
DECREASE HPTA FUNCTION:
ANABOLIC/ ANDROGENIC RATE:
ACTIVE SUBSTANCE: Tirzepatide

Products are shipping without brand label for security reasons.

120.00 USD  

Add in Cart - Product(s)

Close Button
Empty

Total Cost: